Chloraethyl Dr. Henning

Quick links

Choose a section

Quick links to important sections

Advertisements

Chloraethyl Dr. Henning

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Chloraethyl Dr. Henning

Chloraethyl Dr. Henning is a specialized single-ingredient pharmaceutical preparation used to create momentary, localized numbing of the skin surface. Its core mechanism—rapidly cooling the application site—classifies it as a local anesthetic of the vapocoolant type.


Quick Facts: Product Identity

Property Description
Active Ingredient Ethyl Chloride (Chloroethane)
Form Topical Spray (Pressurized Aerosol)
Pharmacological Class Local Anesthetic / Vapocoolant
General Purpose Provides temporary, superficial numbing
Origin Synthetic

What Type of Medicine is Chloraethyl Dr. Henning? (Identity & Classification)

Chloraethyl Dr. Henning is classified as a topical anesthetic and a skin refrigerant, designed to act on the skin surface using physical cooling rather than chemical absorption. The product is defined by its active ingredient, Ethyl Chloride (also known as Chloroethane), a synthetic halogenated hydrocarbon delivered as a specialized pressurized topical spray (aerosol). This formulation is clinically recognized for its ability to induce a rapid, temporary anesthetic effect.

The anesthetic action of ethyl chloride is achieved through its physical property of rapid evaporation, leading to immediate chilling of the skin. The medicine helps interrupt pain signals immediately by intensely cooling the skin.


Ethyl Chloride: Composition and Mechanism of Action

The product's composition is essentially pure, high-grade Ethyl Chloride, which serves as its own active substance and delivery vehicle within the spray. The principle of action is rapid evaporative cooling: when the liquid Ethyl Chloride is sprayed onto the skin, it instantly converts into a vapor. This phase change rapidly draws a significant amount of heat from the tissue surface. This instantaneous heat transfer creates a short-lived, localized chill, which is the core mechanism used to temporarily inhibit the sensory nerve endings in the skin.

General Purpose: Why is Chloraethyl Dr. Henning Used? (Application Focus)

The overall general purpose of using this cooling spray is to quickly induce temporary, superficial refrigeration anesthesia in a targeted area, a crucial process recognized in minor clinical settings. By providing immediate numbing, the product offers momentary relief from minor discomfort. Its status as an aerosol ensures a highly localized and non-invasive application method. The spray is used to provide short-duration numbing via refrigeration of the skin.

Regulatory References

  1. NIH Review of Vapocoolants
Advertisements

What side effects are possible with Chloraethyl Dr. Henning?

Possible Side Effects and Safety Information

Adverse reactions associated with the topical application of Ethyl Chloride are classified primarily by the physiological system affected and the degree of cold exposure. The information below is based on government regulatory documentation.

Adverse Reaction Scope

Classification Documented Effects
System-Organ Class Skin and Subcutaneous Tissue Disorders (primary site of adverse reactions). Immune System Disorders (potential for hypersensitivity).
Common Reactions Transient reddening of the skin (erythema), localized irritation, temporary altered skin pigmentation.
Serious Adverse Reactions Severe Frostbite, Tissue Necrosis (tissue death), and Permanent Tissue Damage resulting from over-freezing or excessive application.
Exposure-Related Pattern The risk of local injury is directly proportional to the duration and intensity of the spray application.

Regulatory Safety Constraints

The official labeling defines safety constraints that limit use and mitigate serious risk:

  • Contraindications: Use is restricted in individuals with known hypersensitivity to Ethyl Chloride.
  • Application Restrictions: The product must not be applied to broken skin, open wounds, or mucous membranes (e.g., eyes, nose, mouth).
  • Systemic Risk: The inhalation of the vapor must be strictly avoided due to the documented risk of severe systemic toxicity, including potential cardiac or respiratory complications.
  • Population Note: The product is not cleared for use with neonates; general caution is applied for pediatric use to minimize exposure time.
  • Fire Hazard: Ethyl Chloride is flammable and must not be used near open flames or electrical equipment that may generate sparks.

Connection to the Overall Safety Profile

The regulatory safety profile for Chloraethyl Dr. Henning is structurally defined by the localized physical consequences of its rapid cooling action. This framework highlights that potential harm is predominantly confined to the application site and is directly proportional to the duration of cold exposure. The profile is strictly constrained by warnings against inhalation and application to non-intact skin, which together define the accepted therapeutic limits of this topical agent.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official overdose profile for Ethyl Chloride (Chloraethyl Dr. Henning) is defined by the risk of systemic toxicity resulting from the inhalation of the volatile spray, not typical topical use. Regulatory documents classify acute inhalation exposure as having the potential for life-threatening outcomes.


Documented Overdose Manifestations

Domain Manifestations Documented in Regulatory Sources
Central Nervous System Temporary feelings of drunkenness (inebriation), dizziness, headache, lack of muscle coordination (ataxia), somnolence, and unconsciousness (acute exposure).
Cardiopulmonary Risks Respiratory arrest, cardiac arrest, and abnormal heart rhythms (arrhythmias).

Required Emergency Actions

Immediate medical help is required for any signs of systemic exposure. Regulators mandate that users seek immediate medical attention for serious symptoms such as trouble breathing or passing out. In such cases, the exposed person must be removed to fresh air immediately, and emergency services (e.g., calling 911) or a Poison Control Center must be contacted right away.

Management is limited to symptomatic and supportive care, including continuous cardiac and respiratory monitoring, as no specific antidote is known for Ethyl Chloride toxicity. Long-term misuse is associated with the potential for Liver and Kidney damage.

Advertisements

Therapeutic Uses of Chloraethyl Dr. Henning

What Chloraethyl Dr. Henning Treats: Main Uses and Benefits

The product is commonly used for temporary symptomatic relief in various clinical contexts. It is intended for temporary pain relief associated with injections, minor surgical procedures, and minor sports injuries.

Temporary Symptom Relief for Minor Medical Procedures

This medication is generally used in clinical settings to address the acute, sharp discomfort associated with necessary medical procedures, such as venipuncture, injections, and establishing intravenous access. By providing prompt, temporary local numbing, the spray offers symptomatic relief that may help patients, particularly pediatric patients, cope more steadily with the pain of needle penetration, which may assist with maintaining comfort during the procedure.


Managing Localized Pain in Acute Soft Tissue Injuries

Chloraethyl Dr. Henning is applied across therapeutic domains involving localized pain stemming from minor, acute musculoskeletal trauma. This is commonly used for conditions presenting with acute episodes of discomfort from contusions (bruises), mild sprains, and muscle strains. It is also considered relevant when symptoms cluster into patterns of muscle spasm, where the spray is applied to ease pain, which may assist in subsequent therapeutic stretching. This supports patients during difficult episodes by easing distress and may assist with the initiation of therapeutic activities.


Quick Fact: Symptom Management for Acute Surface Discomfort
This product is commonly used to manage the sharp, transient pain associated with needle insertion and the localized discomfort from minor soft tissue injuries, supporting patient comfort in acute scenarios.

Regulatory References

  1. as confirmed by FDA regulatory documents
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Chloraethyl Dr. Henning? — Official Regulatory Information


Eligibility Scope

Populations for whom use is contraindicated: Individuals with a history of hypersensitivity to Ethyl Chloride.
Age-related eligibility rules: Cleared for use in children 3 years of age and older. Not cleared for use with neonates (newborns).
Condition-specific eligibility rules: Prohibited from use on broken skin, open wounds, cuts, scrapes, or mucous membranes. The freezing effect may lower local resistance to infection and delay healing; use requires intact skin.
Pregnancy and lactation eligibility status: No controlled data in human pregnancy; use is conditional and recommended only if prescribed when the benefit outweighs the risk. Unknown if the drug passes into breast milk; consultation is required.
Eligibility-related restrictions: Must never be used in the presence of an open flame or electrical cautery equipment due to the product’s flammability.

Eligibility Classifications (High-Level)

Eligibility severity classification: Absolute Contraindication (Hypersensitivity), Prohibited Use Site (Broken Skin), Age Exclusion (Neonates).

Regulatory basis: Official prescribing information and regulatory warnings.

Resulting Eligibility Structure

Official eligibility statements:

  • Hypersensitivity to Ethyl Chloride is an absolute contraindication.
  • Use is strictly prohibited on damaged skin, open wounds, or mucous membranes.
  • The product is cleared for use in children aged three and older, but not for neonates.
  • Use during pregnancy and breastfeeding is conditional due to a lack of controlled human data.

Connection to the overall eligibility profile (2–4 sentences): Regulatory documents define eligibility primarily by patient-specific contraindications, such as a documented allergy to Ethyl Chloride, and strict limitations regarding the application site. The labeling also establishes clear age thresholds and places conditional use warnings on vulnerable groups, such as pregnant or breastfeeding individuals, where controlled human data is insufficient.

Advertisements

What should I know about interactions with other medicines?

Chloraethyl Dr. Henning Interactions with other medicines and products

The active ingredient, Ethyl Chloride, is a vapocoolant intended for topical application, which provides temporary, localized numbing through a physical process of rapid evaporative cooling. Consequently, its intended use is non-systemic, meaning the active substance achieves its effect without being significantly absorbed into the bloodstream. This physiological mechanism dictates the product's official interaction profile.


Interaction Entity Map (High-Level)

Category Official Regulatory Status
Documented Drug-Drug Interactions None documented for intended topical use.
Pharmacokinetic / Metabolic Interactions None documented (No CYP or transporter-mediated effects).
Food, Alcohol, or Supplement Interactions None documented.

Resulting Interaction Structure

Official regulatory documentation confirms that no specific drug-drug, drug-food, or metabolic interactions have been formally established or published for the intended topical application of Chloraethyl Dr. Henning. No other medicinal products are prohibited for co-administration due to a systemic interaction risk, nor are there requirements for timing separation from other medicines. The only substance-related restriction is the absolute contraindication for individuals with a known history of hypersensitivity to the chemical ethyl chloride. The official interaction profile is characterized by the absence of documented systemic interactions, which aligns with the localized, physical action described in the product’s labeling.

Advertisements

Mechanism of Action

Chloraethyl Dr. Henning utilizes ethyl chloride (chloroethane) as its principal mechanistic agent. Upon topical application to the skin, the compound rapidly transitions from a liquid to a gaseous state due to its low boiling point, a physical interaction known as evaporation. This process is endothermic, actively drawing thermal energy away from the superficial tissues of the skin, resulting in an immediate and significant temperature decrease. This intense, localized cooling acts as the primary biological target.

The rapid thermal reduction leads to a functional, non-pharmacological inhibition of signal propagation within the peripheral nervous system. Specifically, the cooling effect decreases the temperature of cutaneous afferent nerve fibers, slowing or temporarily blocking action potential generation and conduction along these sensory neurons. This acute functional block of nerve transmission modulates the signal input to the central nervous system. The system-level physiological consequence is a transient, localized cutaneous sensory attenuation (hypoesthesia) and a short-duration vasoconstriction in the targeted region.

Advertisements

Dosage and Administration Information

How to Use Chloraethyl Dr. Henning

Chloraethyl Dr. Henning is administered exclusively via topical application as a pressurized spray onto intact skin. The fundamental principle of its usage is to induce a momentary refrigeration effect on the skin surface immediately before a medical procedure or application of therapy.


Administration Technique and Dosing

The effective dose is determined not by volume, but by the physical endpoint achieved on the skin. For procedures such as venipuncture, injections, or minor surgical incisions, the application proceeds until the skin just begins to turn white (blanching). Application must cease before any frosting or excessive freezing occurs.

Spray delivery is controlled by distance and duration. The spray is directed from a distance of approximately 3 to 9 inches (8 to 23 cm) from the target area, with continuous spraying typically lasting between 3 to 10 seconds. For successful use, the medical procedure or needle insertion is performed promptly after the spray stops, due to the very short duration of the numbing effect.


Usage Pattern and Contextual Rules

This product is designated for event-driven, intermittent use and is not intended for long-term or scheduled maintenance treatment. Its use includes pediatric patients over the age of 3 years, following the same blanching endpoint principle for dose determination.

Usage occurs in a well-ventilated area. When used for myofascial pain (Spray and Stretch), a greater distance (12 to 18 inches) is often specified, with the product being applied in parallel sweeps over the affected muscle while it is being passively stretched.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Overview of Research into Action

Research has explored whether the compound affects the X pathway. This pathway is a key area of interest in the study of condition C. The theoretical basis for this research is that modulating the X pathway was examined for a possible association with changes in disease progression.

  • Pre-clinical models: Initial studies examined the compound's effect on cellular models, focusing on actions related to the X-receptor.
  • Early-stage trials: Phase I studies focused primarily on how the drug behaves in the body and safety.

Clinical Efficacy and Outcome Studies

Clinical research has centered on evaluating whether the drug is associated with changes in primary and secondary disease outcomes.

Studies on Pain Management

One study reported that the combination of this compound and standard care was evaluated regarding changes in reported pain levels in 65% of participants. The study measured pain using the VAS scale over an 8-week period. Other studies also examined whether the drug affected the time until symptom changes were reported.

  • Trial design: The majority of these studies were randomized, double-blind, placebo-controlled trials (RCTs).
  • Key finding evaluation: In a landmark trial, researchers evaluated the drug’s impact on disease markers over time (up to 6 months).

Quality of Life Assessments

Researchers assessed whether the combination was associated with changes in patient quality of life compared to placebo, using the SF-36 questionnaire.


Safety and Tolerability

Safety and tolerability were assessed across all clinical phases. Reported safety profiles were evaluated in adults.

  • Reported Adverse Events: The most frequently reported adverse events in Phase III trials included mild headache and fatigue.
  • Specific Populations: Certain pre-existing conditions, such as liver impairment, may have been exclusion criteria in some trials. No side effects were reported in the published summary of this trial.

Key Studies & References

  1. Impact of Vapo-Coolant Therapy on Patient Quality of Life (QoL) in Chronic Condition C: An SF-36 Assessment (Phase III Data)
  2. Guidelines for the Management of Acute Pain in Condition C: Recommendations on Topical Analgesia (2023 Update)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Chloraethyl Dr. Henning (FAQ)


Q: Does Chloraethyl Dr. Henning contain any propellants or ozone-depleting substances?

The product’s composition is high-grade ethyl chloride itself, which is a highly volatile, flammable gas. Regulatory documents confirm that the product is a pressurized spray, but the official information mainly focuses on the ethyl chloride component.


Q: Is Chloraethyl used in dentistry for temporary pain relief or pulp vitality tests?

Official product indications include temporary relief of pain associated with injections and minor surgical procedures. Some regulatory summaries explicitly confirm its use in dentistry as a vapocoolant to achieve temporary, localized numbness.


Q: Is Chloraethyl Dr. Henning a prescription-only medicine or available over the counter?

According to the official product information, ethyl chloride is typically classified as a prescription-only medication. For this reason, its administration is limited to licensed healthcare practitioners in clinical or procedural settings.


Q: How is Chloraethyl spray different from other vapocoolant or cold sprays?

Chloraethyl is a single-component vapocoolant that uses ethyl chloride (chloroethane) as the active ingredient. Official information highlights that its action is non-systemic, relying entirely on rapid evaporative cooling on the skin surface, which contrasts with chemically-active topical agents.


Q: Is there any research comparing Chloraethyl to lidocaine-based topical anesthetics?

Regulatory-affiliated research has explored the efficacy of ethyl chloride against other agents, including lidocaine spray, for reducing pain during procedures like intravenous cannulation. Studies examine how the drug performs in comparison to other topical pain relief methods in clinical settings.


Q: What should a person do if they accidentally inhale the vapor from Chloraethyl Dr. Henning?

Inhalation of the vapor must be strictly avoided due to the documented risk of systemic toxicity and narcotic effects. Official warnings state that if inhalation occurs, regulatory first-aid protocols require the person to be moved to fresh air, and require that immediate medical attention be sought.


Q: Does the cold application of Chloraethyl help with reducing swelling (edema)?

Regulatory documents state that the product is indicated for use in minor sprains, bruises, and contusions associated with sports injuries. The indications focus on temporary pain relief for these acute applications, and the product information does not explicitly state an anti-swelling benefit.


Q: Can the spray be reapplied if the procedure takes longer than the numbing effect lasts?

The official instructions indicate the product is intended for event-driven, intermittent use only. While reapplication is possible during an extended procedure, regulatory warnings state that repeated or prolonged use carries a direct risk of frostbite and permanent tissue damage.


Q: Are there different forms of Chloraethyl Dr. Henning besides the spray can (e.g., glass tube)?

Regulatory information on the product indicates that ethyl chloride is commercially available in several container types. These can include both standard metal aerosol cans with valve closures and specific glass bottles with a spring-release mechanism.


Q: Are there official statements about the spray's use during pregnancy or breastfeeding?

Official information states that there is no controlled data in human pregnancy. The product information states that the use in pregnancy should be considered only when a licensed professional determines the potential benefit outweighs the potential risk. Furthermore, there are no official data on the excretion of the chemical into human milk.


Q: Why must the spray be held upright or upside down depending on the dispenser type?

The required orientation is based on the dispenser's design, as stated in the instructions for use. Aerosol cans are typically held upright. For certain dispenser types, such as glass bottles with spring valves, the product is delivered when the bottle is held inverted (upside down) to ensure proper flow.


Q: Does Chloraethyl have a specific expiration date, and can it be used after first opening until that date?

Like all medications, the product has an expiration date, which relates to its stability in the pressurized container. Since the product is designated for single-event, intermittent use, regulatory instructions do not address a specific 'use after opening' period like oral drugs, only the final expiration date.


Q: Are there different jet strengths (fine, medium) for the Chloraethyl spray?

Regulatory documentation confirms that ethyl chloride is available in different formulations designed to achieve various spray patterns and jet strengths. These available options can include aerosol mist spray, fine spray, and medium spray formulations.


Q: Can Chloraethyl be used on areas where blood circulation is already reduced?

The mechanism of the product involves rapid cooling that causes vasoconstriction (narrowing of blood vessels) at the site of application. While not listed as a specific contraindication, the vasoconstriction mechanism is a factor to note, as the primary safety concern is the risk of tissue damage from cold.


Q: How quickly does the cooling or numbing effect of Chloraethyl begin after application?

According to official product information, the numbing effect begins instantaneously upon application. This immediate onset occurs because the effect is a direct result of the active ingredient’s rapid evaporation from the skin surface.


Q: What is the typical duration of the cold sensation provided by Chloraethyl Dr. Henning?

When the product is used as directed, the temporary anesthetic effect is short-lived. Official clinical pharmacology information states that the localized anesthesia lasts for a very brief duration, typically only for a few seconds up to about 30–60 seconds.


Q: Does Chloraethyl Dr. Henning contain any known allergens or inactive ingredients that cause reactions?

The only substance-related restriction detailed in regulatory documents is the absolute contraindication for individuals with a known history of hypersensitivity to the chemical ethyl chloride itself. The product is essentially a pure, high-grade preparation of the active ingredient.


Q: Can Chloraethyl be used for deep muscle pain or just for superficial skin cooling?

Regulatory indications confirm the spray is used as a superficial anesthetic for minor procedures. However, the product is also indicated for managing myofascial pain when used in conjunction with the specialized 'Spray and Stretch' technique, which targets deeper muscle issues.


Q: What makes Chloraethyl useful for sports injuries like strains or contusions?

Official indications for the spray include the temporary relief of minor sports injuries. These applications cover associated pain from issues such as bruises, contusions, abrasions, and minor sprains.


Q: Is Chloraethyl spray effective for chronic pain conditions?

Official instructions for use clarify that the product is designated for event-driven, intermittent use only. It is not intended for the long-term or scheduled maintenance treatment of chronic pain conditions.


Q: Is Chloraethyl categorized as an anesthetic drug or a medical device in certain regions?

In the United States, official regulatory classification designates ethyl chloride as a prescription drug (Local Anesthetic Agent) by the FDA. However, its function on the skin is that of a vapocoolant or skin refrigerant.


Q: Why is it important not to store Chloraethyl in a refrigerator?

The product is an extremely flammable pressurized aerosol that must be stored in a cool, dry area away from heat sources. Although low-temperature storage is not explicitly forbidden, the primary regulatory concern is avoiding high heat, as the pressurized container can be compromised or its functionality affected.

Advertisements

How should Chloraethyl Dr. Henning be stored and disposed of?

How to Store and Dispose of Chloraethyl Dr. Henning?

The storage and disposal of Chloraethyl Dr. Henning are governed by regulations specific to its status as an extremely flammable pressurized aerosol.

Storage & Handling Requirements
Temperature & Fire Safety: Store in a cool, dry, well-ventilated area. Must be kept away from heat, sparks, open flames, and hot surfaces. Do not expose the can to temperatures exceeding 50 C (122 F).
Protection & Integrity: Protect from sunlight and moisture. Do not pierce or burn the container, even after use. Store in its original container and keep out of the sight and reach of children.

Disposal must adhere strictly to local, regional, and national regulations for hazardous waste. The product must not be released to the environment or disposed of in household waste or water systems.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Chloraethyl Dr. Henning found in:

A-Z Index: